Life Sciences/Biotech

ApoLife ? Producing Effective, Affordable Therapeutics for Patients

PLYMOUTH - Nalini Motwani's professional career has certainly taken her on unexpected journeys. She graduated from the University of Bombay with a degree in microbiology at age 19, earned her doctorate at Wayne State University and received a National Institutes of Health fellowship to do postdoctoral research at Oakland University. She has also been a

By |2011-03-12T00:00:00-05:00March 12th, 2011|Archive, Life Sciences/Biotech|

Wayne State Researcher Develops Therapy To Fool Cancer To Kill Itself

DETROIT - A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves. The unique concept, patented by Wayne State University, was successfully demonstrated on melanoma cells

By |2011-03-03T00:00:00-05:00March 3rd, 2011|Archive, Life Sciences/Biotech|

Perrigo Says FDA At Allegan Plant To Reinspect Drug Production Equipment

ALLEGAN - Perrigo Tuesday announced that the Detroit office of the Food and Drug Administration has arrived to reinspect its facilities for equipment failures last spring that included inadequate handling of metal shavings in a batch of bottles to be filled with Ibuprofen tablets. In the case of the metal shavings, Perrigo caught the problem

By |2011-03-01T00:00:00-05:00March 1st, 2011|Archive, Life Sciences/Biotech|

Michigan’s Biosciences Legislative Caucus Advocacy Season Begins

ANN ARBOR - The Michigan Biosciences Legislative Caucus kicks off 2011 with new leadership and scheduled quarterly meetings, MichBio, the state life sciences trade association reported. The body will be led by Sens. Rebekah Warren (D-Ann Arbor, a founding co-chair) and Tonya Schuitmaker (R-Kalamazoo), and Reps. Gail Haines (R-Waterford) and Roy Schmidt (Grand Rapids) in

By |2011-01-25T00:00:00-05:00January 25th, 2011|Archive, Life Sciences/Biotech|

gloStream Releases Next Version Of Electronic Medical Record, Practice Management Software

TROY - gloStream, an electronic medical record and practice management software with Microsoft Office built in ? announced the release of gloEMR 6.0., the sixth major upgrade to the gloEMR product line. Like its predecessor versions, gloEMR 6.0 leverages a variety of Microsoft technology such as the .NET platform, SQL Server and Microsoft Office so

By |2011-01-12T00:00:00-05:00January 12th, 2011|Archive, Life Sciences/Biotech|

Neogen Names Quinlan as CFO

LANSING ? Neogen has named Steven J. Quinlan as the Company's chief financial officer to replace the retiring Richard Current. Current will immediately relinquish his responsibilities as CFO, but will remain with Neogen through the end of the fiscal year, May 31. Quinlan joins Neogen following 19 years at Detrex Corporation, the last eight as

By |2011-01-09T00:00:00-05:00January 9th, 2011|Archive, Life Sciences/Biotech|

Esperion Therapeutics Starts Phase 2 Trail On Anti Cholestrol Drug

PLYMOUTH - Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, Thursday announced that it has initiated a Phase 2 clinical study for small molecule compound that has the potential to regulate cholesterol, triglycerides and other cardio risk factors. ETC-1002 is a novel small molecule

By |2011-01-06T00:00:00-05:00January 6th, 2011|Archive, Life Sciences/Biotech|

Integrated Sensing Systems Gets 2 Federal Grants For Heart Failure Sensor

YPSILANTI - Integrated Sensing Systems has received two federal grants to aid in the support of its wireless implantable pressure sensors for the chronic treatment of congestive heart failure, as well as its drug infusion flow sensing technology for much safer drug administration. ISSYS applied for these grants earlier in the year under the Qualifying

By |2010-12-22T00:00:00-05:00December 22nd, 2010|Archive, Life Sciences/Biotech|

ProNAi Therapeutics ? A New Hope for Cancer Treatment

KALAMAZOO - ProNAi Therapeutics is a drug development and discovery company founded by pharmaceutical development professionals who chose to stay in Michigan when Pfizer shut down operations in Kalamazoo. A biopharmaceutical company located at Kalamazoo's Southwest Michigan Innovation Center, ProNAi is pioneering a new class of therapies for treating cancer; therapies that use naturally occurring

By |2010-12-05T00:00:00-05:00December 5th, 2010|Archive, Life Sciences/Biotech|